HIV Diagnostics Market Size to Reach USD 7.62 Billion in 2028, CAGR:10.1% | Reports and Data

NEW YORK, July 28, 2021 /PRNewswire/ -- The global HIV diagnostics market size is expected to reach USD 7.62 Billion in 2028 and register a CAGR of 10.1% over the forecast period, according to the latest report by Reports and Data. High adoption rate of home kits for diagnosis of HIV and increasing investment by private as well as government organizations to develop more effective diagnostic techniques is driving global HIV diagnostics market revenue growth.

Reports and Data Logo

Initiatives taken by National Aids Control Organization NACO and World Health Organization (WHO) to promote safe blood transfusion and donation is expected to drive growth of the HIV diagnostics market. Approximately 1.2 million individuals in the U.S. suffer from HIV, including 161,800 of whom are unaware that they are living with the disease. Around 40% of new HIV infections are transmitted by persons who are unaware of their status. For people with undiagnosed HIV, testing is the first step to maintaining a healthy life and preventing further transmission.

Request free sample of this research report at:

Emergence of Point of Care (POC) testing in HIV diagnosis has led to the healthcare industry leveraging new innovations in POC instruments via R&D. POC devices are easy to operate and maintain and can be transported conveniently. It also eliminates the need for laboratory technicians to operate the device. Recent advancements in POC testing has resulted in development of Antiretroviral Therapy (ART), Cluster Of Differentiation 4 (CD4) tests, HIV Rapid Diagnostic Tests (RDTs), Viral Load (VL) testing, and HIV Early-Infant Diagnosis (EID) tests. However, limited access to HIV diagnostics in underdeveloped and low-income countries can hamper market growth.

Some Key Highlights From the Report

  • In May 2020, the Bethlehem company's OraSure announced acquisition of HIV diagnostic testing company, UrSure Inc. in a USD 31 million deal. The deal will support OraSure's research in diagnostic testing, as the company is the only one with over-the-counter HIV-rapid test approved by the U.S. Food and Drug Administration (FDA).
  • Antibody test segment accounted for largest revenue share in 2020 as these tests are commonly used to detect HIV antibodies in the human body through saliva or blood. The immune system produces antibodies when virus or bacteria enter the body. Most common antibody test for detection of HIV is ELISA (enzyme-linked immunosorbent assay). It has high specificity and sensitivity and also offers better accuracy as compared to other techniques.

To identify the key trends in the industry, click on the link below:

  • Software & services segment is expected to register a rapid revenue growth rate during the forecast period as an increasing number of researchers are entering the field and use of powerful software to test samples has also been increasing. Software & services segment revenue is also increasing due to rising focus by market players on providing more efficient diagnostic services and increasing R&D activities in genomics.
  • Hospitals segment accounted for a significantly large share in 2020 due to increase in number of hospitals to treat HIV patients in developed as well as developing countries. Governments across the globe are investing in healthcare infrastructure to treat the disease. Integration of advanced and rapid testing kits is also fueling revenue growth of this segment and the trend is expected to continue over the forecast period.
  • HIV diagnostics market in Asia Pacific is expected to register a rapid revenue growth rate during the forecast period due to increasing need to test for HIV in countries in the region. Increase in medical research initiatives in countries such as India, China, and Indonesia, and lack of precautions among sex worker and younger individuals is also fueling demand for HIV diagnostics.
  • Major players in the market include Abbott Laboratories, Becton, Dickinson & Company, Siemens Healthineers, Beckman Coulter, Inc., Hologic Inc., Roche Diagnostics, Thermo-Fisher Scientific Inc., Bio-Rad Laboratories, Bristol-Myers Squibb, and Gilead Sciences.

Order Now:

For the purpose of this report, Reports and Data has segmented the global HIV diagnostics market based on product, test type, end-use, and region:

  • Product Outlook (Revenue, USD Billion; 2018–2028)
    • Consumables
      • a. Assays and Kits & Reagents
      • b. Other Consumables
    • Instruments
    • Software & Services
  • Test Type Outlook (Revenue, USD Billion; 2018–2028)
    • Antibody Tests
      • a.  HIV-1 Screening Tests
        • ELISA
        • Rapid Tests
        • Home Access Dried Blood Spot
      • b.  HIV-1 Confirmatory Tests
        • Western Blot Tests
        • Indirect Immune Fluorescent Antibody Assays (IFA)
        • Line Immunoassays (LIA)
        • Radio-Immunoprecipitation Assays (RIPA)
      • c.  HIV-2 & Group O Diagnostic Tests
    • Viral Load Tests
    • CD4 Tests
    • Tests for Early Infant Diagnosis
    • Tests for Viral Identification
  • End-use Outlook (Revenue, USD Billion; 2018–2028)
    • Diagnostic Laboratories
    • Hospitals
    • Blood Banks
    • Home Care Settings
  • Regional Outlook (Revenue, USD Billion; 2018–2028)
    • North America
      • a.  U.S.
      • b.  Canada
      • c.  Mexico
    • Europe
      • a.  Germany
      • b.  U.K.
      • c.  France
      • d.  Spain
      • e.  BENELUX
      • f.  Switzerland
      • g.  Rest of Europe
    • Asia Pacific
      • a.  China
      • b.  India
      • c.  Japan
      • d.  South Korea
      • e.  Rest of APAC
    • Latin America
      • a.  Brazil
      • b.  Rest of LATAM
    • Middle East & Africa
      • a.  Saudi Arabia
      • b.  UAE
      • c.  Israel
      • d.  Rest Of MEA

Browse Similar Reports by Diagnostics Industry

Point of Care Molecular Diagnostics Market Analysis, By Product And Services (Assay Kits, Software, And Services), By Technology (PCR, IN-Situ Hybridization), By Application (Oncology), By End Use (Decentralized Labs, Hospitals), And Forecasts To 2026

Cardiac Monitoring Market Size, Share & Analysis By Type (ECG devices, Event Monitors, Cardiac Output Monitoring, Implantable Loop Recorders, Mobile Cardiac Telemetry Monitoring (MCT), By End Use (Hospitals, Clinics) Forecasts To 2027

Tissue Diagnostics Market By Type (Diagnostic Kits, Antibodies, Slide Training System, Tissue Processing System), By Technology (Immunohistochemistry, In Situ Hybridization, Digital Pathology & Workflow, Primary & Special Training, Anatomic Pathology, By Application, By End-user, 2017-2027

Allergy Diagnostic Assay Kits Market Growth, Trends & Analysis, By Product Type (Allergen Screening, Allergen Classification Test), By Application (Inhaled Allergens Assay, Food Allergens Assay), By End-Use (Diagnostics Laboratories, Hospital-Based Laboratories, Academic & Research Institutes, Others), And Region, Forecast To 2027

Breast Cancer Diagnostics Market Size, Share & Analysis, By Test Type (Imaging, Biopsy, Genomic Test, Blood Test, Others), By Breast Cancer Type (Ductal Carcinoma In Situ, Invasive Ductal Carcinoma, Inflammatory Breast Cancer, Metastatic Breast Cancer), By End-User (Hospitals & Clinics, Diagnostic Centers, Research Institutes, Others), And Region, Segment Forecasts To 2027

Cancer Diagnostics Market Size, Share & Analysis, By Test Type (Imaging, Laboratory Test, Genetic Test, Biopsy, Endoscopy, Others), By Application (Breast Cancer, Colorectal Cancer, Cervical Cancer, Lung Cancer, Prostate Cancer, Skin Cancer, Blood Cancer, Ovarian Cancer, Others), By End-User (Hospitals & Clinics, Diagnostic Centers, Research Institutes, Others), And Region, Segment Forecasts To 2027

Point-of-Care Glucose Testing Market Size, Share & Analysis, By Product Type (Strips, Lancets & Lancing Devices, Meters), By Testing Site (Fingertip, Alternate Site Testing), By End-use (Professional Diagnostic Centers, Hospitals & Clinics, Home Care Settings, Others), By Region, Forecast To 2028

About Reports and Data 

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client's make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

Contact Us:

John W
Head of Business Development
Reports And Data | Web:
Direct Line: +1-212-710-1370
LinkedIn | Twitter | Blogs
Read full Press Release at:

Cision View original content:

SOURCE Reports And Data

News, commentary and research reports are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.